| Digital twins for multiple sclerosis I Voigt, H Inojosa, A Dillenseger, R Haase, K Akgün, T Ziemssen Frontiers in immunology 12, 669811, 2021 | 135 | 2021 |
| Patient-reported outcomes in multiple sclerosis care E D'Amico, R Haase, T Ziemssen Multiple sclerosis and related disorders 33, 61-66, 2019 | 116 | 2019 |
| Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS K Akgün, N Kretschmann, R Haase, U Proschmann, HH Kitzler, ... Neurology: Neuroimmunology & Neuroinflammation 6 (3), e555, 2019 | 105 | 2019 |
| Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study R Haase, T Schultheiss, R Kempcke, K Thomas, T Ziemssen Journal of medical Internet research 14 (5), e2133, 2012 | 103 | 2012 |
| Perceptions on the value of bodily functions in multiple sclerosis C Heesen, R Haase, S Melzig, J Poettgen, M Berghoff, F Paul, U Zettl, ... Acta Neurologica Scandinavica 137 (3), 356-362, 2018 | 94 | 2018 |
| Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey R Haase, JS Kullmann, T Ziemssen Therapeutic advances in neurological disorders 9 (4), 250-263, 2016 | 74 | 2016 |
| Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation K Thomas, T Sehr, U Proschmann, FA Rodriguez-Leal, R Haase, ... Journal of Neuroinflammation 14, 1-13, 2017 | 64 | 2017 |
| Digital Biomarkers in Multiple Sclerosis A Dillenseger, ML Weidemann, K Trentzsch, H Inojosa, R Haase, ... Brain Sciences 11 (11), 1519, 2021 | 54 | 2021 |
| Designing an electronic patient management system for multiple sclerosis: building a next generation multiple sclerosis documentation system R Kern, R Haase, JC Eisele, K Thomas, T Ziemssen Interactive journal of medical research 5 (1), e4549, 2016 | 51 | 2016 |
| Long-term Effects of Bio-electromagnetic-energy-regulation Therapy on Fatigue in Patients With Multiple Sclerosis. J Piatkowski, R Haase, T Ziemssen Alternative Therapies in Health & Medicine 17 (6), 2011 | 47 | 2011 |
| Serum and plasma levels of vascular endothelial growth factors in relation to quality of glucose control, biomarkers of inflammation, and diabetic nephropathy M Hanefeld, D Appelt, K Engelmann, D Sandner, SR Bornstein, X Ganz, ... Hormone and Metabolic Research 48 (08), 529-534, 2016 | 46 | 2016 |
| Sudomotor testing of diabetes polyneuropathy SM Krieger, M Reimann, R Haase, E Henkel, M Hanefeld, T Ziemssen Frontiers in neurology 9, 803, 2018 | 45 | 2018 |
| Fear of falling and falls in people with multiple sclerosis: A literature review M Scholz, R Haase, K Trentzsch, ML Weidemann, T Ziemssen Multiple sclerosis and related disorders 47, 102609, 2021 | 40 | 2021 |
| Real world lab data: patterns of lymphocyte counts in fingolimod treated patients M Kaufmann, R Haase, U Proschmann, T Ziemssen, K Akgün Frontiers in Immunology 9, 418464, 2018 | 40 | 2018 |
| Differentiating societal costs of disability worsening in multiple sclerosis NH Ness, D Schriefer, R Haase, B Ettle, C Cornelissen, T Ziemssen Journal of neurology 267, 1035-1042, 2020 | 39 | 2020 |
| Modern communication technology skills of patients with multiple sclerosis R Haase, T Schultheiss, R Kempcke, K Thomas, T Ziemssen Multiple Sclerosis Journal 19 (9), 1240, 2013 | 35 | 2013 |
| Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice M Scholz, R Haase, D Schriefer, I Voigt, T Ziemssen Brain Sciences 11 (2), 180, 2021 | 34 | 2021 |
| Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approach R Haase, M Wunderlich, A Dillenseger, R Kern, K Akgün, T Ziemssen Expert opinion on drug safety 17 (4), 369-378, 2018 | 30 | 2018 |
| Real-world lab data in natalizumab treated multiple sclerosis patients up to 6 years long-term follow up M Kaufmann, R Haase, U Proschmann, T Ziemssen, K Akgün Frontiers in Neurology 9, 420813, 2018 | 28 | 2018 |
| Data collection in multiple sclerosis: the MSDS approach T Ziemssen, R Kern, I Voigt, R Haase Frontiers in Neurology 11, 520373, 2020 | 26 | 2020 |
Tjalf ZiemssenUKDVerified email at uniklinikum-dresden.de
